Preview

Рецепт

Расширенный поиск

Актуальные вопросы болезни (синдрома) Кавасаки у детей

https://doi.org/10.34883/PI.2021.24.1.008

Полный текст:

Аннотация

В статье представлены современные сведения о болезни (синдроме) Кавасаки у детей. Проведен анализ доступных литературных данных об этиологии, патогенезе, эпидемиологии, диагностике, клинических признаках, принципах терапии и динамического наблюдения за пациентами с данной патологией. Особое внимание уделено генетическим факторам, предрасполагающим к болезни Кавасаки. Представлена клиническая картина болезни с подробным описанием основных и дополнительных симптомов. Освещены проблемы развития осложнений со стороны сердечно-сосудистой системы в виде формирования аневризм и тромбозов коронарных сосудов в связи с поздней постановкой диагноза и неадекватной терапией. Изучен эффект от внутривенного введения иммуноглобулина в сочетании с ацетилсалициловой кислотой.

Об авторах

В. П. Грынчак
Городская детская инфекционная клиническая больница
Беларусь


Г. М. Батян
Белорусский государственный медицинский университет
Беларусь


А. В. Сукало
Белорусский государственный медицинский университет
Беларусь


Список литературы

1. Lyskina G. (2011) Klinika, diagnostika i lechenie sindroma Kavasaki. Klinicheskie rekomendacii [Clinic, diagnosis and treatment of Kawasaki syndrome. Clinical recommendations]. All-Russian Public Organization Association of Children’s Cardiologists of Russia, pp. 1–57.

2. Baranov A. (2017) Obzor klinicheskih rekomendacij po bolezni/sindromu Kavasaki [Overview of clinical recommendations of the Kawasaki disease / syndrome]. Pediatric pharmacology, vol. 14, no 2, pp. 87–99.

3. McCrindle B.W. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease. A Scientific Statement for Health Professionals from the American Heart Association. Сirculation, vol. 135, no 17, pp. e927–e999.

4. Ozen S. (2006) EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis, vol. 65, no 7, pp. 936–941.

5. Kawasaki T. (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi, vol. 16, pp. 178–222.

6. Dolbnja S. (2015) Sindrom Kavasaki u detej (obzor literatury i demonstracija klinicheskogo sluchaja) [Kawasaki syndrome in children (literature review and clinical case demonstration)]. Bulletin of a young scientist, vol. 3, pp. 53–59.

7. Lyskina G. (2002) Sistemnye vaskulity [Systemic vasculitis]. Detskaja revmatologija: ruk. dlja vrachej [Children’s rheumatology: guide for doctors], Moscow: Medicine, pp. 221–270.

8. Lyskina G. (2008) Slizisto-kozhnyj limfonoduljarnyj sindrom (sindrom Kavasaki). Diagnostika i lechenie [Mucocutaneous lymphonodular syndrome (Kawasaki syndrome). Diagnosis and treatment]. Jetiologija, patogenez. Klinicheskaja kartina. Porazhenie serdechno-sosudistoj sistemy. Instrumental’naja diagnostika. Diagnoz, differencial’nyj diagnoz. Metody lechenija, prognoz. Sobstvennye nabljudenija [Etiology, pathogenesis. The clinical picture. Failure of the cardiovascular system. Instrumental diagnostics. Diagnosis, differential diagnosis. Methods of treatment, prognosis. Our own observations], Moscow: Vidar-M, pp. 3–56.

9. Uehara R., Belay E.D. (2012) Epidemiology of Kawasaki Disease in Asia, Europe and the United States. J Epidemiol, vol. 22, no 2, pp. 79–85.

10. Leontieva A. (2014) Porazhenie serdca i koronarnyh arterij pri sindrome Kavasaki [Damage to the heart and coronary arteries in Kawasaki syndrome]. Russian Bulletin of Perinatology and Pediatrics, vol. 6, pp. 25–31.

11. Lyskina G. (2004) Problemy zabolevanij soedinitel’noj tkani u detej [Problems of connective tissue diseases in children]. Pediatrics. Journal named after G.N. Speransky, vol. 83, no 2, pp. 46–52.

12. Lyskina G., Shirinskaja O. (2013) Klinicheskaja kartina, diagnostika i lechenie sindroma Kavasaki: izvestnye fakty i nereshjonnye problemy [The clinical picture, diagnosis and treatment of Kawasaki syndrome: known facts and unsolved problems]. Questions of modern pediatrics, vol. 12, no 1, pp. 63–73.

13. Orenstein J.M. (2013) Three links vasculopathic process Characterize Kawasaki Disease: a light and transmission electron microscopic study.National Institutes of health, vol. 7, pp. 1–24.

14. Abstracts of the 10th International Kawasaki Disease Symposium, Kyoto, Japan, February 7–10, 2012 (2012) Pediatr Int, vol. 54, suppl. 1, pp. 38–142.

15. Centers for Disease Control and Prevention. Kawasaki Disease. Available at: http://www.cdc.gov/kawasaki.

16. Huang W.C. (2009) Epidemiologic features of Kawasaki disease in Taiwan, 2003–2006. Pediatrics, vol. 123, no 3, pp. e401–е405.

17. Harnden А. (2009) Kawasaki disease in England: ethnicity, deprivation, and respiratory pathogens. Pediatr Infect Dis J, vol. 28, iss. 1, pp. 21–24.

18. Newburger J.W. (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics, vol. 114, pp. 1708–1733.

19. Batjan G., Sukalo A., Hrynchak V. (2019) Bolezn’ Kavasaki u detej: vos’miletnij opyt lechenija i dispansernogo nabljudenija [Kawasaki disease in children: eight years of experience in treatment and follow-up]. Clinical Infectology and Parasitology, vol. 8, no 4, pp. 614–622.

20. Tamrazova O., Tebenkov A., Tebenkova T. (2013) Bolezn’ Kavasaki: sovremennyj vzgljad na jetiologiju i patogenez, klinicheskie nabljudenija, taktika vedenija bol’nyh [Kawasaki disease: a modern view of the etiology and pathogenesis, clinical observations, management tactics]. Consilium medicum: pediatrics, vol. 3, pp. 85–89.

21. Lyskina G. (2009) Klinika i diagnostika slizisto-kozhnogo limfonoduljarnogo sindroma (sindroma Kavasaki) [Clinic and diagnosis of mucocutaneous lymphonodular syndrome (Kawasaki syndrome)]. Doctor.Ru, vol. 1, no 45, pp. 13–18.

22. Kafetzis D.A. (2001) Lack of association between Kawasaki syndrome and infection with Rickettsia conorii, Rickettsia typhi, Coxiella burnetii or Ehrlichia phagocytophila group. Pediatr. Infect. Dis. J, vol. 20, pp. 703–706.

23. Leung D.Y. (1987) Immunologic abnormalities in Kawasaki syndrome. Prog Clin Biol Res, vol. 250, pp. 159–165.

24. Benseler S.M. (2005) Infections and Kawasaki disease: implications for coronary artery outcome. Pediatrics, vol. 116, pp. e760–e766.

25. Meissner H.C., Leung D.Y. (2000) Superantigens, conventional antigens and the etiology of Kawasaki syndrome. Pediatr Infect Dis J, vol. 9, pp. 91–94.

26. Kikuta Н., Matsumoto S., Osato Т. (1991) Kawasaki disease and Epstein-Barr virus. Acta Paediatr Jpn., vol. 33, pp. 765–770.

27. Rowley А.Н. (2011) Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a “new” virus associated with Kawasaki disease. J Infect Dis., vol. 203, pp. 1021–1030.

28. Verdoni L. (2020) An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.Lancet, vol. 395, iss. 102396, pp. 1771–1778.

29. Alizargar J. (2020) The novel coronavirus (COVID-19) and the risk of Kawasaki disease in children. J Formos Med Assoc. doi: 10.1016/ j.jfma.2020.05.030

30. Makino N. (2015) Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. J Epidemiol, vol. 25, iss. 3, pp. 239–245.

31. Gedike G., Hotama P.D., Hajnking B. (2010) Bolezn’ Kavasaki – novye dannye [Kawasaki disease – new data]. Questions of modern pediatrics, vol. 9, no 1, pp. 104–115.

32. Vatutin N., Iofe E. (2019) Bolezn’ kavasaki [Kawasaki disease]. Bulletin of emergency and reconstructive surgery, vol. 4, no 2, pp. 16–22.

33. Rowley А.Н. (1987) Incomplete Kawasaki disease with coronary artery involvement. J Pediatr, vol. 110, iss. 3, pp. 409–413.

34. Papadodima S.A. (2009) Atypical Kawasaki disease presenting with symptoms from the genitourinary system: an autopsy report. J Trop Pediatr, vol. 55, iss. 1, pp. 55–57.

35. McCrindle B.W. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation, vol. 135, iss. 17, pp. 927–999.

36. Suda K. (2011) Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: a single-institution experience.Circulation, vol. 123, iss. 17, pp. 1836–1842.

37. Newburger J.W. (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: A Statement for Health Professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics, vol. 114, pp. 1708–1733.

38. Ogata S. (2009) The strategy of immune globulin resistant Kawasaki disease: A comparative study of additional immune globulin and steroid pulse therapy. J. Cardiol, vol. 53, pp. 15–19.

39. Kanamitsu K. (2016) Verification of risk scores to predict intravenous immunoglobulin resistance in incomplete Kawasaki disease. Pediatr. Int, vol. 58, iss. 2, pp. 146–151.

40. Nakagama Y. (2016) Fever pattern and C-reactive protein predict response to rescue therapy in Kawasaki disease. Pediatr. Int, vol. 58, iss. 3, pp. 180–184.

41. Saneeymehri S., Baker K., So T.Y. (2015) Overview of pharmacological treatment options for pediatric patients with refractory Kawasaki disease.J. Pediatr. Pharmacol. Ther, vol. 3, pp. 163–177.

42. Batjan G.M. (2012) Dispansernyj jetap nabljudenija pacientov s bolezn’ju Kavasaki [Dispensary phase of monitoring patients with Kawasaki disease]. Available at: https://www.bsmu.by/files/fa50fbb12ec3c2855bd866e2f54a0847/ (accessed June 1, 2020).

43. Batjan G., Buldyk E. (2012) Ispol’zovanie vnutrivennyh immunoglobulinov pri bolezni Kavasaki u detej [The use of intravenous immunoglobulins in Kawasaki disease in children]. Available at: https://www.bsmu.by/files/c9a663a4d7cbd4ee60f59b4539f92bb4/ (accessed June 1, 2020).


Для цитирования:


Грынчак В.П., Батян Г.М., Сукало А.В. Актуальные вопросы болезни (синдрома) Кавасаки у детей. Рецепт. 2021;(1):90-100. https://doi.org/10.34883/PI.2021.24.1.008

For citation:


Hrynchak .V., Batsian .G., Sukalo .A. Actual Issues of the Kawasaki Disease (Syndrome) in Children. Recipe. 2021;(1):90-100. (In Russ.) https://doi.org/10.34883/PI.2021.24.1.008

Просмотров: 26


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1993-4882 (Print)
ISSN 2414-2263 (Online)